Literature DB >> 3092894

Hyperalimentation of jaundiced patients on percutaneous transhepatic biliary drainage.

D Foschi, G Cavagna, F Callioni, E Morandi, V Rovati.   

Abstract

Although percutaneous transhepatic biliary drainage (PTBD) restores hepatic and renal function in patients with obstructive jaundice, it is not certain whether it reduces the rate of complications and death after biliopancreatic surgery. We studied the possibility that the operative risks of jaundiced patients are related to malnutrition and the usefulness of hyperalimentation with PTBD to reduce the incidence of complications. Sixty-four patients with obstructive jaundice and serum bilirubin greater than 200 mumol/l were randomized into two treatment groups (n = 32) with PTBD or PTBD + hyperalimentation. Four patients were withdrawn from the latter group, two for metastatic cancer and two for complications of PTBD. Before starting hyperalimentation, the incidence of malnutrition was assessed by biochemical, immunological and anthropometric tests: malnutrition was found in 70 per cent of the patients. All the patients had good recovery of hepatic function but patients treated with PTBD alone still had high mortality (12.5 per cent) and morbidity (46.8 per cent) after biliopancreatic surgery. When hyperalimentation was provided to patients on PTBD for a period of 20 days before the operation, the incidence of complications fell to 17.8 per cent and mortality to 3.5 per cent. These results suggest that the combined use of PTBD and hyperalimentation, improving both hepatic function tests and the nutritional status of jaundiced patients, can reduce the rate of complications after biliary and pancreatic surgery.

Entities:  

Mesh:

Year:  1986        PMID: 3092894     DOI: 10.1002/bjs.1800730914

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  9 in total

Review 1.  Nutritional support for liver disease.

Authors:  Ronald L Koretz; Alison Avenell; Timothy O Lipman
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

2.  Factors affecting morbidity and mortality in biliary tract surgery.

Authors:  C H Su; F K P'eng; W Y Lui
Journal:  World J Surg       Date:  1992 May-Jun       Impact factor: 3.352

3.  Changing patterns in diagnosis and management of bile duct cancer.

Authors:  R K Tompkins; K Saunders; J J Roslyn; W P Longmire
Journal:  Ann Surg       Date:  1990-05       Impact factor: 12.969

Review 4.  [Perioperative protection of the gastrointestinal tract].

Authors:  K Weismüller; S Hofer; M A Weigand
Journal:  Anaesthesist       Date:  2012-08       Impact factor: 1.041

Review 5.  Is there a role for parenteral feeding in clinical medicine?

Authors:  S D Phinney; J Siepler; H T Bach
Journal:  West J Med       Date:  1996-02

Review 6.  Nutrition support in hospitalised adults at nutritional risk.

Authors:  Joshua Feinberg; Emil Eik Nielsen; Steven Kwasi Korang; Kirstine Halberg Engell; Marie Skøtt Nielsen; Kang Zhang; Maria Didriksen; Lisbeth Lund; Niklas Lindahl; Sara Hallum; Ning Liang; Wenjing Xiong; Xuemei Yang; Pernille Brunsgaard; Alexandre Garioud; Sanam Safi; Jane Lindschou; Jens Kondrup; Christian Gluud; Janus C Jakobsen
Journal:  Cochrane Database Syst Rev       Date:  2017-05-19

7.  External biliary drainage plus bile acid feeding is not equal to internal drainage in preserving the cellular immunity following prolonged obstructive jaundice.

Authors:  K T Mok; B W Wang; H C Chang; S L Lin
Journal:  Dig Dis Sci       Date:  2001-09       Impact factor: 3.199

8.  Role of parenteral nutrition in preventing malnutrition and decreasing bacterial translocation to liver in obstructive jaundice.

Authors:  J H Chuang; C S Shieh; N K Chang; W J Chen; J N Lin
Journal:  World J Surg       Date:  1993 Sep-Oct       Impact factor: 3.352

Review 9.  Contemporary enteral and parenteral nutrition before surgery for gastrointestinal cancers: a literature review.

Authors:  Michal Jankowski; Manuela Las-Jankowska; Massaoud Sousak; Wojciech Zegarski
Journal:  World J Surg Oncol       Date:  2018-05-16       Impact factor: 2.754

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.